Aegirbio | vd-intervju

27 January 2021 - 22:00
BioStock intervjuar Martin Linde, vd Aegirbio....
Nasdaq First North GM Stockholm (Sweden)
AegirBio AB
AegirBio is a Swedish diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Monator - drug monitoring of tysabri in MS, Veritope, and Magniareader....
Learn more about company

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More